Use of pharmacogenetics to optimize immunosuppressive therapy.

Macphee, Iain A M

Macphee, Iain A M.

Affiliation

Macphee IA; St. George's, University of London, London, UK. imacphee@sgul.ac.uk

Ther Drug Monit ; 32(3): 261-4, 2010 Jun.

Article in En | MEDLINE | ID: mdl-20431509

Subject(s)

Cytochrome P-450 CYP3A/blood; Immunosuppressive Agents/blood; Pharmacogenetics/methods; Tacrolimus/blood; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1/blood; ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics; Cyclosporine/blood; Cytochrome P-450 CYP3A/genetics; Genotype; Humans; IMP Dehydrogenase/blood; IMP Dehydrogenase/genetics; Immunosuppression Therapy/methods; Immunosuppressive Agents/pharmacokinetics; Kidney Transplantation/immunology; Polymorphism, Genetic/immunology; Sirolimus/blood

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pharmacogenetics / Tacrolimus / Cytochrome P-450 CYP3A / Immunosuppressive Agents Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Year: 2010 Type: Article

Fulltext

XML

PubMed Links

Search on Google